Determining optimal conditions for collection and processing of metastatic liver biopsies collected for a multicenter, prospective study to identify biomarkers of clinical resistance to first-line therapy in metastatic colorectal cancer

Zuanel Diaz

Determining optimal conditions for collection and processing of metastatic liver biopsies collected for a multicenter, prospective study to identify biomarkers of clinical resistance to first-line therapy in metastatic colorectal cancer

Zuanel Diaz

Research output: Contribution to conference › Presentation

Original language	American English
State	Published - Mar 2012
Event	Quebec Conference on Therapeutic Resistance in Cancer - Montreal, Canada Duration: Mar 1 2012 → …

Conference

Conference	Quebec Conference on Therapeutic Resistance in Cancer
Period	3/1/12 → …

Disciplines

Medicine and Health Sciences
Neoplasms
Oncology

Cite this

Determining optimal conditions for collection and processing of metastatic liver biopsies collected for a multicenter, prospective study to identify biomarkers of clinical resistance to first-line therapy in metastatic colorectal cancer. / Diaz, Zuanel.
2012. Quebec Conference on Therapeutic Resistance in Cancer.

Research output: Contribution to conference › Presentation

@conference{7955853c7f134564a0febd250beb326d,

title = "Determining optimal conditions for collection and processing of metastatic liver biopsies collected for a multicenter, prospective study to identify biomarkers of clinical resistance to first-line therapy in metastatic colorectal cancer",

author = "Zuanel Diaz",

year = "2012",

month = mar,

language = "American English",

note = "Quebec Conference on Therapeutic Resistance in Cancer ; Conference date: 01-03-2012",

}

TY - CONF

T1 - Determining optimal conditions for collection and processing of metastatic liver biopsies collected for a multicenter, prospective study to identify biomarkers of clinical resistance to first-line therapy in metastatic colorectal cancer

AU - Diaz, Zuanel

PY - 2012/3

Y1 - 2012/3

M3 - Presentation

T2 - Quebec Conference on Therapeutic Resistance in Cancer

Y2 - 1 March 2012

ER -